Advancements In Heart Disease Prediction: A Machine Learning Approach For Early Detection And Risk Assessment
International Journal of Research and Analytical Reviews, IJRAR October 2024, Volume 11, Issue 4 The primary aim of this paper is to comprehend, assess, and analyze the role, relevance, and efficiency of machine learning models in predicting heart disease risks using clinical data. While the importa...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | International Journal of Research and Analytical Reviews, IJRAR
October 2024, Volume 11, Issue 4 The primary aim of this paper is to comprehend, assess, and analyze the role,
relevance, and efficiency of machine learning models in predicting heart
disease risks using clinical data. While the importance of heart disease risk
prediction cannot be overstated, the application of machine learning (ML) in
identifying and evaluating the impact of various features on the classification
of patients with and without heart disease, as well as in generating a reliable
clinical dataset, is equally significant. This study relies primarily on
cross-sectional clinical data. The ML approach is designed to enhance the
consideration of various clinical features in the heart disease prognosis
process. Some features emerge as strong predictors, adding significant value.
The paper evaluates seven ML classifiers: Logistic Regression, Random Forest,
Decision Tree, Naive Bayes, k-Nearest Neighbors, Neural Networks, and Support
Vector Machine (SVM). The performance of each model is assessed based on
accuracy metrics. Notably, the Support Vector Machine (SVM) demonstrates the
highest accuracy at 91.51%, confirming its superiority among the evaluated
models in terms of predictive capability. The overall findings of this research
highlight the advantages of advanced computational methodologies in the
evaluation, prediction, improvement, and management of cardiovascular risks. In
other words, the strong performance of the SVM model illustrates its
applicability and value in clinical settings, paving the way for further
advancements in personalized medicine and healthcare. |
---|---|
DOI: | 10.48550/arxiv.2410.14738 |